PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-25.13%
Revenue decline while VET shows 23.95% growth. Joel Greenblatt would examine competitive position erosion.
1.04%
Cost growth less than half of VET's 18.68%. David Dodd would verify if cost advantage is structural.
-45.65%
Gross profit decline while VET shows 28.34% growth. Joel Greenblatt would examine competitive position.
-27.41%
Margin decline while VET shows 3.54% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
32.50%
G&A growth while VET reduces overhead. John Neff would investigate operational differences.
No Data
No Data available this quarter, please select a different quarter.
13800.00%
Other expenses growth above 1.5x VET's 416.67%. Michael Burry would check for concerning trends.
29.32%
Operating expenses growth above 1.5x VET's 4.57%. Michael Burry would check for inefficiency.
12.60%
Similar total costs growth to VET's 12.26%. Walter Schloss would investigate norms.
-11.96%
Interest expense reduction while VET shows 6.97% growth. Joel Greenblatt would examine advantage.
9.09%
D&A growth 50-75% of VET's 15.21%. Bruce Berkowitz would examine asset strategy.
-72.90%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-60.31%
EBITDA margin decline while VET shows 9.45% growth. Joel Greenblatt would examine position.
-134.42%
Operating income decline while VET shows 82.66% growth. Joel Greenblatt would examine position.
-145.98%
Operating margin decline while VET shows 47.36% growth. Joel Greenblatt would examine position.
40.68%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
-238.13%
Both companies show declining income. Martin Whitman would check industry conditions.
-284.49%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-877.78%
Both companies reducing tax expense. Martin Whitman would check patterns.
-200.00%
Both companies show declining income. Martin Whitman would check industry conditions.
-233.57%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-200.00%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-198.75%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
-2.86%
Share count reduction while VET shows 9.00% change. Joel Greenblatt would examine strategy.
-1.18%
Diluted share reduction while VET shows 8.29% change. Joel Greenblatt would examine strategy.